Molecular Subtyping of Early-Stage Breast Cancer Identifies a Group of Patients Who Do Not Benefit from Neoadjuvant Chemotherapy
PUBLICATION: Breast Cancer Res Treat. 2013 Jun;139(3):759-67. doi: 10.1007/s10549-013-2572-4. AUTHORS: Read More
PUBLICATION: Breast Cancer Res Treat. 2013 Jun;139(3):759-67. doi: 10.1007/s10549-013-2572-4. AUTHORS: Read More
CHICAGO – Molecular subtyping can help predict outcomes and chemotherapy Read More
PUBLICATION: Breast Cancer Res Treat. 2013 Jun;139(3):621-37. doi: 10.1007/s10549-013-2559-1. Epub Read More
IRVINE, CA, May 31, 2013 – Agendia, a world leader Read More
IRVINE, CA, May 2, 2013 – Agendia, a world leader Read More
Agendia Announces Launch of ColoPrint for Colon Cancer Prognosis and Prediction
KARE, Minneapolis-St.Paul-2013 This TV report tells how you can “know Read More
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, February 4, 2013 – Read More
IRVINE, CA, and AMSTERDAM, THE NETHERLANDS, January 25, 2013 – Read More